DOT1L and colorectal carcinoma: To examine whether the TCF4-MLLT10/AF10-DOT1L interaction is mediated by β-catenin, we used an Ls174T CRC cell line that inducibly expresses a shRNA against β-catenin in response to doxycycline treatment [5].